PMC:7264098 / 20311-20414 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7264098","sourcedb":"PMC","sourceid":"7264098","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7264098","text":"Extracellular vesicles (EVs) are emerging as an attractive alternative to the whole cell–based therapy.","tracks":[{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T306","span":{"begin":0,"end":22},"obj":"GO:1903561"},{"id":"T82799","span":{"begin":0,"end":22},"obj":"GO:1903561"}],"attributes":[{"subj":"T306","pred":"source","obj":"LitCovid-PMC-OGER-BB"},{"subj":"T82799","pred":"source","obj":"LitCovid-PMC-OGER-BB"}]},{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T149","span":{"begin":84,"end":88},"obj":"Body_part"}],"attributes":[{"id":"A149","pred":"fma_id","subj":"T149","obj":"http://purl.org/sig/ont/fma/fma68646"},{"subj":"T149","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T216","span":{"begin":84,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"attributes":[{"subj":"T216","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T120","span":{"begin":0,"end":103},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T120","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PMC-OGER-BB","color":"#93ecdf","default":true},{"id":"LitCovid-PD-FMA-UBERON","color":"#ecc493"},{"id":"LitCovid-PD-CLO","color":"#aa93ec"},{"id":"LitCovid-sentences","color":"#95ec93"}]}]}}